We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

288 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

18% more funds holding in top 10

Funds holding in top 10: 1113 (+2)

2% more funds holding

Funds holding: 283288 (+5)

0.07% more ownership

Funds ownership: 94.92%94.99% (+0.07%)

0% less capital invested

Capital invested by funds: $2.86B → $2.85B (-$5.8M)

11% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 104

82% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $94.3M

Holders
288
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.16%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.19%
New
42
Increased
93
Reduced
104
Closed
32
Calls
$17.1M
Puts
$94.3M
Net Calls
-$77.2M
Net Calls Change
-$8.21M
Name Holding Trade Value Shares
Change
Change in
Stake
Pacer Advisors
176
Pacer Advisors
Pennsylvania
$448K +$2.04K +22 +0.5%
GCM
177
Graham Capital Management
Connecticut
$420K +$424K +4,572 New
VOYA Investment Management
178
VOYA Investment Management
Georgia
$415K +$63.1K +680 +18%
Pictet Asset Management
179
Pictet Asset Management
Switzerland
$396K
Creative Planning
180
Creative Planning
Kansas
$394K +$27.4K +295 +7%
Pathstone Holdings
181
Pathstone Holdings
New Jersey
$387K -$31.5K -339 -7%
X
182
Xponance
Pennsylvania
$381K -$91.7K -988 -19%
Commonwealth Equity Services
183
Commonwealth Equity Services
Massachusetts
$381K +$38K +409 +11%
PNC Financial Services Group
184
PNC Financial Services Group
Pennsylvania
$378K -$7.42K -80 -2%
Franklin Resources
185
Franklin Resources
California
$372K +$376K +4,056 New
US Bancorp
186
US Bancorp
Minnesota
$364K -$41.2K -444 -10%
II
187
Inspire Investing
Idaho
$351K -$4.83K -52 -1%
TC
188
Trium Capital
United Kingdom
$339K +$343K +3,693 New
PA
189
Parallel Advisors
California
$339K +$76.7K +827 +29%
State of Tennessee, Department of Treasury
190
State of Tennessee, Department of Treasury
Tennessee
$334K +$338K +3,643 New
First Eagle Investment Management
191
First Eagle Investment Management
New York
$324K
SOADOR
192
State of Alaska Department of Revenue
Alaska
$323K
HighTower Advisors
193
HighTower Advisors
Illinois
$320K +$2.5K +27 +0.8%
Public Employees Retirement Association of Colorado
194
Public Employees Retirement Association of Colorado
Colorado
$316K -$14K -151 -4%
GITFIT
195
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)
Poland
$312K
RAM
196
Resona Asset Management
Japan
$309K +$312K +3,364 New
AG
197
Algert Global
California
$302K +$305K +3,292 New
Federated Hermes
198
Federated Hermes
Pennsylvania
$287K -$15.2K -164 -5%
D.E. Shaw & Co
199
D.E. Shaw & Co
New York
$283K -$131K -1,414 -31%
IIM
200
INTECH Investment Management
Florida
$280K +$283K +3,054 New

AMED Hedge Fund Activity: Q2 2024 in Review

288 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2024, worth a combined $2.85B — down 0.2% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 32 closed out — a net gain of 10 holders — while 93 added to existing stakes and 104 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $96.9M. The largest seller was Millennium Management, cutting an estimated $32.3M.

  • 288 institutional investors held Amedisys (AMED) as of Q2 2024, up from 283 in Q1 2024.
  • Funds reported $2.85B of Amedisys stock for Q2 2024, down 0.2% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q2 2024 and 32 closed out, a net change of +10 holders.
  • The largest Amedisys buyer in Q2 2024 was Goldman Sachs, an estimated $96.9M added.
  • The largest Amedisys seller in Q2 2024 was Millennium Management, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2024.